-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
What is the reason for the falsely high drug prices? A few days ago, the Ministry of Finance issued fines to 19 drug companies that violated regulations, opening the "black box" of falsely high drug prices.
Among the 19 illegal pharmaceutical companies that were punished, there were many well-known pharmaceutical companies such as Hengrui Pharmaceuticals and Buchang Pharmaceuticals.
In addition, Sanofi, Merck Serono, Eli Lilly and other foreign-funded pharmaceutical companies are also on the penalty list.
Among the 19 illegal pharmaceutical companies that were punished, there were many well-known pharmaceutical companies such as Hengrui Pharmaceuticals and Buchang Pharmaceuticals.
In addition, Sanofi, Merck Serono, Eli Lilly and other foreign-funded pharmaceutical companies are also on the penalty list.
It is understood that the purpose of this law enforcement inspection is to find out the cause of the falsely high drug prices, and the results of the law enforcement inspection also show that the falsely high drug prices are not on the cost side, but mostly occur in the intermediate links.
The sales expenses of some pharmaceutical companies remain high.
According to media reports, the sales expenses of listed pharmaceutical companies even account for 60% of their revenue.
The sales expenses of some pharmaceutical companies remain high.
According to media reports, the sales expenses of listed pharmaceutical companies even account for 60% of their revenue.
Pharmaceutical companies use false invoices and bills to arbitrage funds, fabricate business matters, or use pharmaceutical promotion companies to arbitrage funds to open up sales links.
Among them, Jiangsu Worldbest Pharmaceutical Co.
, Ltd.
in 2018 to pay personal marketing pharmnet.
com.
cn/agent_product/" target="_blank">agency business sales promotion expenses, the attached part of the invoice is issued by a third party with no real business of the company, involving an amount of 140 million yuan.
Changbaishan Pharmaceutical Co.
, Ltd.
inflated staff salaries by 7,222,500 yuan in 2018, and inflated travel expenses by 21,624,300 yuan by over-reporting the number of days the sales staff were on business.
These hidden expenses in the middle of travel expenses and promotion expenses are the reason for the high drug prices, and consumers and patients are undoubtedly paying the bills.
Among them, Jiangsu Worldbest Pharmaceutical Co.
, Ltd.
in 2018 to pay personal marketing pharmnet.
com.
cn/agent_product/" target="_blank">agency business sales promotion expenses, the attached part of the invoice is issued by a third party with no real business of the company, involving an amount of 140 million yuan.
Changbaishan Pharmaceutical Co.
, Ltd.
inflated staff salaries by 7,222,500 yuan in 2018, and inflated travel expenses by 21,624,300 yuan by over-reporting the number of days the sales staff were on business.
These hidden expenses in the middle of travel expenses and promotion expenses are the reason for the high drug prices, and consumers and patients are undoubtedly paying the bills.
Evident that only the cost of the middle part of the firm sales down eradicate drugs illicit production and marketing chain, "rentier", drug prices in order to squeeze out the water, so that the health insurance funds actually used to enhance medical services, reduce The medical burden of the majority of patients.
In this regard, it is necessary to adhere to the principles of zero tolerance and strict supervision, form a combined force of supervision, increase the intensity of financial and accounting supervision and law enforcement, and create a clear intermediate link.
Judging from the punishment results, although the Ministry of Finance imposes a maximum fine on illegal pharmaceutical companies , the maximum fine is only 50,000 yuan, which is not the pain of fines for violating companies, compared with the thousands or even hundreds of millions of false funds involved in violations.
Therefore, laws and regulations such as the accounting law must also be revised and improved, penalties must be substantially increased, and the cost of violations must be increased to form a powerful deterrent.
Judging from the punishment results, although the Ministry of Finance imposes a maximum fine on illegal pharmaceutical companies , the maximum fine is only 50,000 yuan, which is not the pain of fines for violating companies, compared with the thousands or even hundreds of millions of false funds involved in violations.
Therefore, laws and regulations such as the accounting law must also be revised and improved, penalties must be substantially increased, and the cost of violations must be increased to form a powerful deterrent.
On the other hand, it is necessary to increase the implementation of the centralized government procurement system, reduce the intermediate links of drug sales, and reduce the space for benefit transmission in the process of drug sales.
Practice has also proved that after the implementation of centralized government procurement, the prices of many medicines have fallen sharply, and the effect is very obvious.
In addition, it is necessary to increase financial investment in public hospitals , improve the treatment of medical staff, eradicate the soil of "medicine to support doctors", and improve the quality of the public welfare of basic medical and health undertakings.
(TextYang Sanxi)
Practice has also proved that after the implementation of centralized government procurement, the prices of many medicines have fallen sharply, and the effect is very obvious.
In addition, it is necessary to increase financial investment in public hospitals , improve the treatment of medical staff, eradicate the soil of "medicine to support doctors", and improve the quality of the public welfare of basic medical and health undertakings.
(TextYang Sanxi)
What is the reason for the falsely high drug prices? A few days ago, the Ministry of Finance issued fines to 19 drug companies that violated regulations, opening the "black box" of falsely high drug prices.
Among the 19 illegal pharmaceutical companies that were punished, there were many well-known pharmaceutical companies such as Hengrui Pharmaceuticals and Buchang Pharmaceuticals.
In addition, Sanofi, Merck Serono, Eli Lilly and other foreign-funded pharmaceutical companies are also on the penalty list.
Among the 19 illegal pharmaceutical companies that were punished, there were many well-known pharmaceutical companies such as Hengrui Pharmaceuticals and Buchang Pharmaceuticals.
In addition, Sanofi, Merck Serono, Eli Lilly and other foreign-funded pharmaceutical companies are also on the penalty list.
It is understood that the purpose of this law enforcement inspection is to find out the cause of the falsely high drug prices, and the results of the law enforcement inspection also show that the falsely high drug prices are not on the cost side, but mostly occur in the intermediate links.
The sales expenses of some pharmaceutical companies remain high.
According to media reports, the sales expenses of listed pharmaceutical companies even account for 60% of their revenue.
The sales expenses of some pharmaceutical companies remain high.
According to media reports, the sales expenses of listed pharmaceutical companies even account for 60% of their revenue.
Pharmaceutical companies use false invoices and bills to arbitrage funds, fabricate business matters, or use pharmaceutical promotion companies to arbitrage funds to open up sales links.
Among them, Jiangsu Worldbest Pharmaceutical Co.
, Ltd.
in 2018 to pay personal marketing pharmnet.
com.
cn/agent_product/" target="_blank">agency business sales promotion expenses, the attached part of the invoice is issued by a third party with no real business of the company, involving an amount of 140 million yuan.
Changbaishan Pharmaceutical Co.
, Ltd.
inflated staff salaries by 7,222,500 yuan in 2018, and inflated travel expenses by 21,624,300 yuan by over-reporting the number of days the sales staff were on business.
These hidden expenses in the middle of travel expenses and promotion expenses are the reason for the high drug prices, and consumers and patients are undoubtedly paying the bills.
Among them, Jiangsu Worldbest Pharmaceutical Co.
, Ltd.
in 2018 to pay personal marketing pharmnet.
com.
cn/agent_product/" target="_blank">agency business sales promotion expenses, the attached part of the invoice is issued by a third party with no real business of the company, involving an amount of 140 million yuan.
Changbaishan Pharmaceutical Co.
, Ltd.
inflated staff salaries by 7,222,500 yuan in 2018, and inflated travel expenses by 21,624,300 yuan by over-reporting the number of days the sales staff were on business.
These hidden expenses in the middle of travel expenses and promotion expenses are the reason for the high drug prices, and consumers and patients are undoubtedly paying the bills.
Evident that only the cost of the middle part of the firm sales down eradicate drugs illicit production and marketing chain, "rentier", drug prices in order to squeeze out the water, so that the health insurance funds actually used to enhance medical services, reduce The medical burden of the majority of patients.
In this regard, it is necessary to adhere to the principles of zero tolerance and strict supervision, form a combined force of supervision, increase the intensity of financial and accounting supervision and law enforcement, and create a clear intermediate link.
Judging from the punishment results, although the Ministry of Finance imposes a maximum fine on illegal pharmaceutical companies , the maximum fine is only 50,000 yuan, which is not the pain of fines for violating companies, compared with the thousands or even hundreds of millions of false funds involved in violations.
Therefore, laws and regulations such as the accounting law must also be revised and improved, penalties must be substantially increased, and the cost of violations must be increased to form a powerful deterrent.
Judging from the punishment results, although the Ministry of Finance imposes a maximum fine on illegal pharmaceutical companies , the maximum fine is only 50,000 yuan, which is not the pain of fines for violating companies, compared with the thousands or even hundreds of millions of false funds involved in violations.
Therefore, laws and regulations such as the accounting law must also be revised and improved, penalties must be substantially increased, and the cost of violations must be increased to form a powerful deterrent.
On the other hand, it is necessary to increase the implementation of the centralized government procurement system, reduce the intermediate links of drug sales, and reduce the space for benefit transmission in the process of drug sales.
Practice has also proved that after the implementation of centralized government procurement, the prices of many medicines have fallen sharply, and the effect is very obvious.
In addition, it is necessary to increase financial investment in public hospitals , improve the treatment of medical staff, eradicate the soil of "medicine to support doctors", and improve the quality of the public welfare of basic medical and health undertakings.
(TextYang Sanxi)
Practice has also proved that after the implementation of centralized government procurement, the prices of many medicines have fallen sharply, and the effect is very obvious.
In addition, it is necessary to increase financial investment in public hospitals , improve the treatment of medical staff, eradicate the soil of "medicine to support doctors", and improve the quality of the public welfare of basic medical and health undertakings.
(TextYang Sanxi)
What is the reason for the falsely high drug prices? A few days ago, the Ministry of Finance issued fines to 19 drug companies that violated regulations, opening the "black box" of falsely high drug prices.
Among the 19 illegal pharmaceutical companies that were punished, there were many well-known pharmaceutical companies such as Hengrui Pharmaceuticals and Buchang Pharmaceuticals.
In addition, Sanofi, Merck Serono, Eli Lilly and other foreign-funded pharmaceutical companies are also on the penalty list.
Among the 19 illegal pharmaceutical companies that were punished, there were many well-known pharmaceutical companies such as Hengrui Pharmaceuticals and Buchang Pharmaceuticals.
In addition, Sanofi, Merck Serono, Eli Lilly and other foreign-funded pharmaceutical companies are also on the penalty list.
It is understood that the purpose of this law enforcement inspection is to find out the cause of the falsely high drug prices, and the results of the law enforcement inspection also show that the falsely high drug prices are not on the cost side, but mostly occur in the intermediate links.
The sales expenses of some pharmaceutical companies remain high.
According to media reports, the sales expenses of listed pharmaceutical companies even account for 60% of their revenue.
The sales expenses of some pharmaceutical companies remain high.
According to media reports, the sales expenses of listed pharmaceutical companies even account for 60% of their revenue.
Pharmaceutical companies use false invoices and bills to arbitrage funds, fabricate business matters, or use pharmaceutical promotion companies to arbitrage funds to open up sales links.
Among them, Jiangsu Worldbest Pharmaceutical Co.
, Ltd.
in 2018 to pay personal marketing pharmnet.
com.
cn/agent_product/" target="_blank">agency business sales promotion expenses, the attached part of the invoice is issued by a third party with no real business of the company, involving an amount of 140 million yuan.
Changbaishan Pharmaceutical Co.
, Ltd.
inflated staff salaries by 7,222,500 yuan in 2018, and inflated travel expenses by 21,624,300 yuan by over-reporting the number of days the sales staff were on business.
These hidden expenses in the middle of travel expenses and promotion expenses are the reason for the high drug prices, and consumers and patients are undoubtedly paying the bills.
pharmnet. Among them, Jiangsu Worldbest Pharmaceutical Co.
, Ltd.
in 2018 to pay personal marketing pharmnet.
com.
cn/agent_product/" target="_blank">agency business sales promotion expenses, the attached part of the invoice is issued by a third party with no real business of the company, involving an amount of 140 million yuan.
Changbaishan Pharmaceutical Co.
, Ltd.
inflated staff salaries by 7,222,500 yuan in 2018, and inflated travel expenses by 21,624,300 yuan by over-reporting the number of days the sales staff were on business.
These hidden expenses in the middle of travel expenses and promotion expenses are the reason for the high drug prices, and consumers and patients are undoubtedly paying the bills.
com.
cn/agent_product/" target="_blank">Agentpharmnet.
com.
cn/agent_product/" target="_blank"> Agent Agent
Evident that only the cost of the middle part of the firm sales down eradicate drugs illicit production and marketing chain, "rentier", drug prices in order to squeeze out the water, so that the health insurance funds actually used to enhance medical services, reduce The medical burden of the majority of patients.
Medicine, medicine, medicine In this regard, it is necessary to adhere to the principles of zero tolerance and strict supervision, form a combined force of supervision, increase the intensity of financial and accounting supervision and law enforcement, and create a clear intermediate link.
Judging from the punishment results, although the Ministry of Finance imposes a maximum fine on illegal pharmaceutical companies , the maximum fine is only 50,000 yuan, which is not the pain of fines for violating companies, compared with the thousands or even hundreds of millions of false funds involved in violations.
Therefore, laws and regulations such as the accounting law must also be revised and improved, penalties must be substantially increased, and the cost of violations must be increased to form a powerful deterrent.
Pharmaceutical companies Pharmaceutical pharmaceutical business enterprisesJudging from the punishment results, although the Ministry of Finance imposes a maximum fine on illegal pharmaceutical companies , the maximum fine is only 50,000 yuan, which is not the pain of fines for violating companies, compared with the thousands or even hundreds of millions of false funds involved in violations.
Therefore, laws and regulations such as the accounting law must also be revised and improved, penalties must be substantially increased, and the cost of violations must be increased to form a powerful deterrent.
On the other hand, it is necessary to increase the implementation of the centralized government procurement system, reduce the intermediate links of drug sales, and reduce the space for benefit transmission in the process of drug sales.
Practice has also proved that after the implementation of centralized government procurement, the prices of many medicines have fallen sharply, and the effect is very obvious.
In addition, it is necessary to increase financial investment in public hospitals , improve the treatment of medical staff, eradicate the soil of "medicine to support doctors", and improve the quality of the public welfare of basic medical and health undertakings.
(TextYang Sanxi)
Hospital hospital hospital Practice has also proved that after the implementation of centralized government procurement, the prices of many medicines have fallen sharply, and the effect is very obvious.
In addition, it is necessary to increase financial investment in public hospitals , improve the treatment of medical staff, eradicate the soil of "medicine to support doctors", and improve the quality of the public welfare of basic medical and health undertakings.
(TextYang Sanxi)
